Showing results (441-450 of 458) with videos related to
Sort By:
Pageof 46
Nature|December 8, 1983
Neuropeptide Y distribution in human brainT E Adrian, J M Allen, S R Bloom, et al.The British Journal of Psychiatry : the Journal of Mental Science|March 1, 1979
Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findingsT J Crow, H F Baker, A J Cross, et al.Archives of General Psychiatry|December 1, 1989
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the diseaseT J Crow, J Ball, S R Bloom, et al.Neuropharmacology|December 1, 1984
Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicidesT J Crow, A J Cross, S J Cooper, et al.Biological Psychiatry|October 18, 2000
No evidence for a parent-of-origin effect detected in the pattern of inheritance of schizophreniaL E DeLisi, K Razi, J Stewart, et al.Cerebral Cortex (New York, N.Y. : 1991)|January 12, 2013
Sexually dimorphic white matter geometry abnormalities in adolescent onset schizophreniaP Savadjiev, T J Whitford, M E Hough, et al.Brain Research|December 12, 1983
Peptides, the limbic lobe and schizophreniaG W Roberts, I N Ferrier, Y Lee, et al.Life Sciences|August 1, 1983
Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaI N Ferrier, G W Roberts, T J Crow, et al.Brain : a Journal of Neurology|February 1, 1986
Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?J M Allen, A J Cross, J C Yeats, et al.Journal of the Neurological Sciences|December 1, 1983
Neuropeptides in Alzheimer type dementiaI N Ferrier, A J Cross, J A Johnson, et al.Pageof 46